Exact Mass: 410.9383918

Exact Mass Matches: 410.9383918

Found 18 metabolites which its exact mass value is equals to given mass value 410.9383918, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Discorhabdin Q

(-)-16,17-Dehydrodiscorhabdin B

C18H10BrN3O2S (410.967706)


   

Pyridinium-3,5-bisthiocarboxylate mononucleotide; P2TMN; Pyridin-1-ium-3,5-bisthiocarboxylate mononucleotide

Pyridinium-3,5-bisthiocarboxylate mononucleotide; P2TMN; Pyridin-1-ium-3,5-bisthiocarboxylate mononucleotide

C12H14NO9PS2 (410.9847604)


   

Methyl 5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate

Methyl 5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate

C16H12BrClFN3O2 (410.9785394)


   

disodium 5-[(4-nitro-2-sulphonatophenyl)azo]salicylate

disodium 5-[(4-nitro-2-sulphonatophenyl)azo]salicylate

C13H7N3Na2O8S (410.9749262)


   

2-Amino-6-(2-(sulfooxy)ethylsulfonyl)naphthalene-1-sulfonic acid

2-Amino-6-(2-(sulfooxy)ethylsulfonyl)naphthalene-1-sulfonic acid

C12H13NO9S3 (410.97524480000004)


   

r-(+)-2,2-dibromo-1,1-binaphthyl

r-(+)-2,2-dibromo-1,1-binaphthyl

C20H13Br2 (410.9383918)


   

1,5,9-triazacyclotridecane,trihydrobromide

1,5,9-triazacyclotridecane,trihydrobromide

C9H24Br3N3 (410.9520204)


   

ethylenediaminetetraacetic acid disodium cobalt salt, hydrate

ethylenediaminetetraacetic acid disodium cobalt salt, hydrate

C10H14CoN2Na2O9 (410.9826654)


   

A-TOSYL-(4-IODOMETHYLBENZYL)ISOCYANIDE

A-TOSYL-(4-IODOMETHYLBENZYL)ISOCYANIDE

C16H14INO2S (410.9789974)


   

A-TOSYL-(3-IODOMETHYLBENZYL)ISOCYANIDE

A-TOSYL-(3-IODOMETHYLBENZYL)ISOCYANIDE

C16H14INO2S (410.9789974)


   

(1R,3R)-N-[1-(4-bromophenyl)ethyl]-2,2-dichloro-3-methyl-1-[(S)-methylsulfinyl]cyclopropane-1-carboxamide

(1R,3R)-N-[1-(4-bromophenyl)ethyl]-2,2-dichloro-3-methyl-1-[(S)-methylsulfinyl]cyclopropane-1-carboxamide

C14H16BrCl2NO2S (410.9462116)


   

3-[(3,5-Dibromo-6-oxo-1-cyclohexa-2,4-dienylidene)methylamino]-2-methylbenzoic acid

3-[(3,5-Dibromo-6-oxo-1-cyclohexa-2,4-dienylidene)methylamino]-2-methylbenzoic acid

C15H11Br2NO3 (410.91056160000005)


   

N-[5-[(2,6-dichlorophenyl)methylthio]-1,3,4-thiadiazol-2-yl]-5-methyl-2-pyrazinecarboxamide

N-[5-[(2,6-dichlorophenyl)methylthio]-1,3,4-thiadiazol-2-yl]-5-methyl-2-pyrazinecarboxamide

C15H11Cl2N5OS2 (410.9782056)


   

2,4-Dibromo-6-[(2,3-dihydro-1,4-benzodioxin-6-ylamino)methylidene]-1-cyclohexa-2,4-dienone

2,4-Dibromo-6-[(2,3-dihydro-1,4-benzodioxin-6-ylamino)methylidene]-1-cyclohexa-2,4-dienone

C15H11Br2NO3 (410.91056160000005)


   

BX430

BX430

C15H15Br2N3O (410.958178)


BX430 is a potent and selective noncompetitive allosteric human P2X4 receptor channels antagonist with an IC50 of 0.54 μM. BX430 has species specificity. BX430 is used for chronic pain and cardiovascular disease.

   

(3s,10s)-5-bromo-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(21),2(12),4,7,14,16,18-heptaene-6,13-dione

(3s,10s)-5-bromo-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(21),2(12),4,7,14,16,18-heptaene-6,13-dione

C18H10BrN3O2S (410.967706)


   

2-(3,5-dibromo-4-butoxy-1-hydroxy-4-methoxycyclohexa-2,5-dien-1-yl)ethanimidic acid

2-(3,5-dibromo-4-butoxy-1-hydroxy-4-methoxycyclohexa-2,5-dien-1-yl)ethanimidic acid

C13H19Br2NO4 (410.96807340000004)